These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18544960)

  • 1. Translational research in breast cancer.
    Borisch B
    Pathobiology; 2008; 75(2):61-2. PubMed ID: 18544960
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
    Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B
    J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-expression signatures in breast cancer.
    Kopans DB
    N Engl J Med; 2003 Apr; 348(17):1715-7; author reply 1715-7. PubMed ID: 12712995
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment.
    Pandit TS; Kennette W; Mackenzie L; Zhang G; Al-Katib W; Andrews J; Vantyghem SA; Ormond DG; Allan AL; Rodenhiser DI; Chambers AF; Tuck AB
    Int J Oncol; 2009 Aug; 35(2):297-308. PubMed ID: 19578743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
    Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
    Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BRCA1 regulates progesterone receptors A and B protein expressions in breast cancer cells in vitro].
    Guo YX; Zeng WS; Liu YW; Li YS; Lin J; Xiong JB; Luo SQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1157-60. PubMed ID: 18676251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathologic diagnosis of luminal and basal type breast cancer].
    Sarcević B
    Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling: decoding breast cancer.
    de Snoo F; Bender R; Glas A; Rutgers E
    Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gene signature in breast cancer.
    Woodward WA; Lucci A; Cristofanilli M
    N Engl J Med; 2007 May; 356(18):1887-8; author reply 1887-8. PubMed ID: 17479476
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of gene-expression profiling and its clinical use in breast cancer.
    Stadler ZK; Come SE
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):1-11. PubMed ID: 18614375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance.
    Santarpia M; Altavilla G; Margeli M; Cirauqui B; Mesiti M; Cavallari V; Ramirez JL; Sanchez-Ronco M; Santarpia L; Taron M; Rosell R
    Cancer Invest; 2008 Dec; 26(10):1044-51. PubMed ID: 18798071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using hair to screen for breast cancer.
    James V; Kearsley J; Irving T; Amemiya Y; Cookson D
    Nature; 1999 Mar; 398(6722):33-4. PubMed ID: 10078527
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
    Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
    BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular pathology of hereditary breast cancer.
    Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
    Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
    Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
    Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multigene predictors in early-stage breast cancer: moving in or moving out?
    Ross JS
    Expert Rev Mol Diagn; 2008 Mar; 8(2):129-35. PubMed ID: 18366299
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
    Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
    Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.